Published in Pharma Law Weekly, November 29th, 2005
Scientists in Japan conducted a study "to define the distribution of folate receptor beta (FR beta)-expressing cells in various tissues, including rheumatoid arthritis (RA) synovial tissues, and to verify the effects of an immunotoxin composed of an anti-FR beta monoclonal antibody (mAb) and truncated Pseudomonas exotoxin A (PEA) on apoptosis and tumor necrosis factor alpha (TNF alpha) production by adherent synovial mononuclear cells from RA patients."
"Anti-FRO mAb were produced by immunizing mice with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.